IL10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.693420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.380800E-01
Normal-vs-Stage2
4.139800E-01
Normal-vs-Stage3
9.233400E-01
Normal-vs-Stage4
3.300800E-01
Stage1-vs-Stage2
8.357400E-01
Stage1-vs-Stage3
6.189400E-01
Stage1-vs-Stage4
6.594400E-01
Stage2-vs-Stage3
8.196000E-01
Stage2-vs-Stage4
6.530200E-01
Stage3-vs-Stage4
4.937800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.107600E-01
Normal-vs-AfricanAmerican
6.465000E-01
Normal-vs-Asian
6.920400E-01
Caucasian-vs-AfricanAmerican
9.891800E-01
Caucasian-vs-Asian
9.285400E-01
AfricanAmerican-vs-Asian
9.343200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.813600E-02
Normal-vs-Female
9.006600E-01
Male-vs-Female
2.778000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.572400E-01
Normal-vs-Age(41-60Yrs)
9.893000E-01
Normal-vs-Age(61-80Yrs)
3.273700E-02
Normal-vs-Age(81-100Yrs)
8.112200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.430800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.972600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.955200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.904600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.457800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.801400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.227800E-04
Normal-vs-Daily Drinker
2.005000E-01
Normal-vs-Weekly Drinker
2.274800E-01
Normal-vs-Occasional Drinker
8.097100E-03
Normal-vs-Social Drinker
2.411800E-01
Non Drinker-vs-Daily Drinker
4.601600E-01
Non Drinker-vs-Weekly Drinker
1.032850E-01
Non Drinker-vs-Occasional Drinker
7.291600E-01
Non Drinker-vs-Social Drinker
7.284000E-01
Daily Drinker-vs-Weekly Drinker
1.469380E-01
Daily Drinker-vs-Occasional Drinker
3.830200E-01
Daily Drinker-vs-Social Drinker
8.414000E-01
Weekly Drinker-vs-Occasional Drinker
9.380000E-02
Weekly Drinker-vs-Social Drinker
1.357220E-01
Occasional Drinker-vs-Social Drinker
5.857800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.267800E-01
Normal-vs-Grade 2
5.470400E-01
Normal-vs-Grade 3
5.407600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.312000E-02
Grade 1-vs-Grade 3
1.233210E-01
Grade 1-vs-Grade 4
5.267800E-01
Grade 2-vs-Grade 3
4.659200E-01
Grade 2-vs-Grade 4
5.470400E-01
Grade 3-vs-Grade 4
5.407600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.724800E-01
Normal-vs-NonDiabetic
6.663600E-02
Diabetic-vs-NonDiabetic
4.953000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.738170E-01
Normal-vs-NoPancreatitis
1.532230E-01
Pancreatitis-vs-NoPancreatitis
5.731400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.119390E-01
Normal-vs-N1
4.430600E-01
N0-vs-N1
5.107400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.546500E-02
Normal-vs-TP53-NonMutant
6.982400E-01
TP53-Mutant-vs-TP53-NonMutant
3.010000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
